Charles Schwab’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $115M | Sell |
1,622,416
-14,146
| -0.9% | -$764K | 0.02% | 713 |
|
|
2026
Q1 | $85.5M | Buy |
1,636,562
+77,418
| +5% | +$4.65M | 0.01% | 811 |
|
|
2025
Q4 | $91.7M | Sell |
1,559,144
-20,496
| -1% | -$1.25M | 0.01% | 766 |
|
|
2025
Q3 | $87.9M | Buy |
1,579,640
+27,200
| +2% | +$1.46M | 0.01% | 796 |
|
|
2025
Q2 | $79.9M | Buy |
1,552,440
+41,180
| +3% | +$2.07M | 0.01% | 791 |
|
|
2025
Q1 | $88.6M | Buy |
1,511,260
+45,570
| +3% | +$3.09M | 0.02% | 712 |
|
|
2024
Q4 | $106M | Buy |
1,465,690
+51,687
| +4% | +$3.8M | 0.02% | 634 |
|
|
2024
Q3 | $113M | Sell |
1,414,003
-88,911
| -6% | -$6.68M | 0.02% | 598 |
|
|
2024
Q2 | $108M | Buy |
1,502,914
+34,467
| +2% | +$2.54M | 0.02% | 610 |
|
|
2024
Q1 | $103M | Buy |
1,468,447
+28,528
| +2% | +$2.04M | 0.02% | 598 |
|
|
2023
Q4 | $111M | Buy |
1,439,919
+28,095
| +2% | +$1.85M | 0.03% | 511 |
|
|
2023
Q3 | $96.1M | Sell |
1,411,824
-5,340
| -0.4% | -$422K | 0.03% | 518 |
|
|
2023
Q2 | $116M | Buy |
1,417,164
+8,527
| +0.6% | +$685K | 0.03% | 455 |
|
|
2023
Q1 | $105M | Buy |
1,408,637
+9,970
| +0.7% | +$768K | 0.03% | 476 |
|
|
2022
Q4 | $116M | Buy |
1,398,667
+45,083
| +3% | +$3.58M | 0.04% | 429 |
|
|
2022
Q3 | $96.1M | Buy |
1,353,584
+33,232
| +3% | +$2.87M | 0.03% | 461 |
|
|
2022
Q2 | $114M | Buy |
1,320,352
+45,888
| +4% | +$4.3M | 0.04% | 399 |
|
|
2022
Q1 | $138M | Buy |
1,274,464
+43,060
| +3% | +$4.44M | 0.04% | 398 |
|
|
2021
Q4 | $159M | Buy |
1,231,404
+40,544
| +3% | +$4.97M | 0.05% | 365 |
|
|
2021
Q3 | $144M | Buy |
1,190,860
+296,536
| +33% | +$36.1M | 0.05% | 358 |
|
|
2021
Q2 | $101M | Buy |
894,324
+20,192
| +2% | +$2.13M | 0.03% | 488 |
|
|
2021
Q1 | $83.5M | Sell |
874,132
-54,152
| -6% | -$4.94M | 0.03% | 546 |
|
|
2020
Q4 | $73.7M | Buy |
928,284
+15,820
| +2% | +$1.15M | 0.03% | 560 |
|
|
2020
Q3 | $56.5M | Buy |
912,464
+10,048
| +1% | +$654K | 0.03% | 606 |
|
|
2020
Q2 | $59.6M | Sell |
902,416
-81,848
| -8% | -$4.9M | 0.03% | 549 |
|
|
2020
Q1 | $46.7M | Buy |
984,264
+10,060
| +1% | +$503K | 0.03% | 553 |
|
|
2019
Q4 | $53.5M | Buy |
974,204
+46,868
| +5% | +$2.46M | 0.03% | 581 |
|
|
2019
Q3 | $45.4M | Buy |
927,336
+62,284
| +7% | +$3.12M | 0.03% | 643 |
|
|
2019
Q2 | $45.1M | Buy |
865,052
+25,076
| +3% | +$1.26M | 0.03% | 620 |
|
|
2019
Q1 | $41.7M | Buy |
839,976
+20,272
| +2% | +$912K | 0.03% | 640 |
|
|
2018
Q4 | $29.7M | Buy |
819,704
+3,540
| +0.4% | +$148K | 0.02% | 726 |
|
|
2018
Q3 | $41.6M | Sell |
816,164
-278,668
| -25% | -$12.3M | 0.03% | 625 |
|
|
2018
Q2 | $40.5M | Buy |
1,094,832
+105,220
| +11% | +$4.02M | 0.03% | 605 |
|
|
2018
Q1 | $37.4M | Buy |
989,612
+163,572
| +20% | +$5.78M | 0.03% | 616 |
|
|
2017
Q4 | $26.8M | Buy |
826,040
+37,304
| +5% | +$1.19M | 0.02% | 775 |
|
|
2017
Q3 | $23.8M | Buy |
788,736
+52,296
| +7% | +$1.55M | 0.02% | 796 |
|
|
2017
Q2 | $21.6M | Buy |
736,440
+21,788
| +3% | +$596K | 0.02% | 802 |
|
|
2017
Q1 | $18.2M | Buy |
714,652
+56,476
| +9% | +$1.46M | 0.02% | 891 |
|
|
2016
Q4 | $16.9M | Buy |
658,176
+44,068
| +7% | +$1.16M | 0.02% | 868 |
|
|
2016
Q3 | $16.8M | Buy |
614,108
+47,756
| +8% | +$1.31M | 0.02% | 800 |
|
|
2016
Q2 | $16M | Buy |
566,352
+21,712
| +4% | +$558K | 0.02% | 772 |
|
|
2016
Q1 | $12.9M | Buy |
544,640
+23,312
| +4% | +$513K | 0.02% | 880 |
|
|
2015
Q4 | $11.7M | Buy |
521,328
+24,088
| +5% | +$549K | 0.02% | 911 |
|
|
2015
Q3 | $11.5M | Buy |
497,240
+36,692
| +8% | +$920K | 0.02% | 900 |
|
|
2015
Q2 | $11.3M | Buy |
460,548
+38,628
| +9% | +$965K | 0.02% | 936 |
|
|
2015
Q1 | $10.6M | Buy |
421,920
+52,244
| +14% | +$1.24M | 0.01% | 964 |
|
|
2014
Q4 | $8.54M | Buy |
369,676
+28,448
| +8% | +$651K | 0.01% | 1007 |
|
|
2014
Q3 | $7.98M | Buy |
341,228
+16,856
| +5% | +$395K | 0.01% | 996 |
|
|
2014
Q2 | $7.51M | Buy |
324,372
+9,644
| +3% | +$213K | 0.01% | 1063 |
|
|
2014
Q1 | $6.72M | Buy |
314,728
+22,068
| +8% | +$497K | 0.01% | 1092 |
|
|
2013
Q4 | $6.93M | Buy |
292,660
+25,196
| +9% | +$546K | 0.01% | 1002 |
|
|
2013
Q3 | $5.47M | Buy |
267,464
+19,544
| +8% | +$371K | 0.01% | 1101 |
|
|
2013
Q2 | $4.32M | Buy |
+247,920
| New | +$4.12M | 0.01% | 1188 |
|
Other funds holding TECH
HI
Charles Schwab's TECH Position: Q2 2026 in Review
Charles Schwab reduced its Bio-Techne (TECH) stake by 0.86% in Q2 2026, selling an estimated $764K and leaving 1,622,416 shares worth $115M. The position accounts for 0.02% of the portfolio, ranked #713.
Charles Schwab first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $159M in Q4 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Charles Schwab held 1,622,416 shares of Bio-Techne worth $115M as of Q2 2026.
- Charles Schwab sold 14,146 Bio-Techne shares in Q2 2026, an estimated $764K.
- Bio-Techne made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #713 holding.
- Charles Schwab first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Bio-Techne position peaked at $159M in Q4 2021.
- 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.